肾脏病与透析肾移植杂志
• 论文 • 上一篇 下一篇
出版日期:
发布日期:
基金资助:
Online:
Published:
摘要： 肾脏替代治疗（RRT）是急慢性肾功能损害患者重要治疗手段，在RRT下患者的残余肾功能(RRF)是影响患者预后的重要因素，而RRF的评估由于受RRT的影响存在一定困难，寻找新型指标显得很有必要，目前研究较多的指标包括胱抑素C（CysC），β2微球蛋白（β2MG）及β踪迹蛋白（BTP）等。本文将结合近年来相关研究对RRT患者RRF评估进行综述。
关键词: 肾脏替代治疗, 残余肾功能, 胱抑素C, &beta, 2微球蛋白, &beta, 踪迹蛋白
Abstract: Renal replacement therapy(RRT) is the most useful method for treatment of patients with acute or chronic renal dysfunction.In those undergoing RRT,the evaluation of residual renal function,which is a key factor affecting the patients outcomes,is difficult due to RRT effects.The present efforts have been made to investigate the value of using cystatin C (CysC),β2 microglobulin (β2MG) and βtrace protein (BTP) for assessment of RRF.This article will summarize the recent progress in researches on RRF evaluation in patients receiving RRT.
胡臻，龚德华. 肾脏替代治疗患者残余肾功能的测量与评估[J]. 肾脏病与透析肾移植杂志, DOI: 10.3969/j.issn.1006-298X.2020.02.018.
HU Zhen，GONG Dehua. Evaluation of residual renal function in patients receiving renal replacement therapy[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, DOI: 10.3969/j.issn.1006-298X.2020.02.018.
0 / / 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: http://www.njcndt.com/CN/10.3969/j.issn.1006-298X.2020.02.018
http://www.njcndt.com/CN/Y2020/V29/I2/186
